Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
60
about 2.7 years
18+
1 site in TN
What this study is about
This trial is testing how skeletal muscle mitochondria function in people who have survived acute lymphoblastic leukemia (ALL). It involves imaging techniques and blood tests to compare muscle health between ALL survivors and a control group. The goal is to understand the relationship between cancer treatment, muscle weakness, and mitochondrial activity.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Magnetic Resonance Spectroscopy
- 2.Peripheral blood sample
- 3.Physical function assessment
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: To explore feasibility of CrCEST MRI to measure OXPHOS capacity, To explore feasibility of Fat Fraction MRI to measure OXPHOS capacity, To explore feasibility of MRI/MRS to measure OXPHOS capacity, To explore feasibility of Muscle Ultrasound to measure OXPHOS capacity
imaging
Oncology